Zhejiang Medicine Co., Ltd. Class ASSE: 600216

Announcement on Subsidiary Xinchang Pharmaceutical Factory Passing On-site Inspection by FDA of the United States

· Issued by Zhejiang Medicine Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Subsidiary Xinchang Pharmaceutical Factory Passing On-site Inspection by FDA of the United States

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis